TEC. 2008b. Genetic testing for long-QT syndrome. Technology Evaluation Center Assessment Program 22(9):1-5.

TEC. 2011. Epidermal growth factor receptor mutations and tyrosine kinase inhibitor therapy in advanced non-small-cell lung cancer. Technology Evaluation Center Assessment Program 25(6):1-30.

Teutsch, S. M., L. A. Bradley, G. E. Palomaki, J. E. Haddow, M. Piper, N. Calonge, W. D. Dotson, M. P. Douglas, and A. O. Berg. 2009. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: Methods of the EGAPP working group. Genetics in Medicine 11(1):3-14.

Tu, J. V., J. Bowen, M. Chiu, D. T. Ko, P. C. Austin, Y. He, R. Hopkins, J. E. Tarride, G. Blackhouse, C. Lazzam, E. A. Cohen, and R. Goeree. 2007. Effectiveness and safety of drug-eluting stents in Ontario. New England Journal of Medicine 357(14):1393-1402.

Villanueva, J., D. R. Shaffer, J. Philip, C. A. Chaparro, H. Erdjument-Bromage, A. B. Olshen, M. Fleisher, H. Lilja, E. Brogi, J. Boyd, M. Sanchez-Carbayo, E. C. Holland, C. Cordon-Cardo, H. I. Scher, and P. Tempst. 2006. Differential exoprotease activities confer tumorspecific serum peptidome patterns. Journal of Clinical Investigation 116(1):271-284.

Wolff, A. C., M. E. Hammond, J. N. Schwartz, K. L. Hagerty, D. C. Allred, R. J. Cote, M. Dowsett, P. L. Fitzgibbons, W. M. Hanna, A. Langer, L. M. McShane, S. Paik, M. D. Pegram, E. A. Perez, M. F. Press, A. Rhodes, C. Sturgeon, S. E. Taube, R. Tubbs, G. H. Vance, M. van de Vijver, T. M. Wheeler, and D. F. Hayes. 2007. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Journal of Clinical Oncology 25(1):118-145.

Zhu, C. Q., G. da Cunha Santos, K. Ding, A. Sakurada, J. C. Cutz, N. Liu, T. Zhang, P. Marrano, M. Whitehead, J. A. Squire, S. Kamel-Reid, L. Seymour, F. A. Shepherd, and M. S. Tsao. 2008. Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21. Journal of Clinical Oncology 26(26):4268-4275.

Zujewski, J. A., and L. Kamin. 2008. Trial assessing individualized options for treatment for breast cancer: The TAILORx trial. Future Oncology 4(5):603-610.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement